Saundra L. Pelletier, Chief Executive Officer at Evofem Biosciences, Inc. (EVFM), sold 6,705 shares at $6.05 ($41K) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Scheduled sale ($41k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TCON | BUY | 2021-07-27 | $25K | — | Filing → |
| EVFM | BUY | 2021-06-10 | $52K | — | Filing → |
| EVFM | BUY | 2021-03-09 | $206K | — | Filing → |